Cargando…
Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death
Runt-related transcription factor 2 (RUNX2) has been considered to be one of master regulators for osteoblast differentiation and bone formation. Recently, we have described that RUNX2 attenuates p53/TAp73-dependent cell death of human osteosarcoma U2OS cells bearing wild-type p53 in response to adr...
Autores principales: | Sugimoto, H, Nakamura, M, Yoda, H, Hiraoka, K, Shinohara, K, Sang, M, Fujiwara, K, Shimozato, O, Nagase, H, Ozaki, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981025/ https://www.ncbi.nlm.nih.gov/pubmed/27551445 http://dx.doi.org/10.1038/cddiscovery.2015.10 |
Ejemplares similares
-
Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death
por: Sugimoto, H, et al.
Publicado: (2015) -
Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63
por: Ozaki, Toshinori, et al.
Publicado: (2016) -
Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death
por: Nakamura, M, et al.
Publicado: (2016) -
Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63
por: Ogata, Takehiro, et al.
Publicado: (2017) -
Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity
por: Ozaki, Toshinori, et al.
Publicado: (2015)